[Pharmacological properties of a specific Gq/11 inhibitor, YM-254890].
Kawasaki
Tomihisa
T
tomihisa.kawasaki@jp.astellas.com
Uemura
Toshio
T
Taniguchi
Masatoshi
M
Takasaki
Jun
J
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology; D043802:GTP-Binding Protein alpha Subunits, Gq-G11 / Q000037:antagonists & inhibitors*; D066298:In Vitro Techniques; D051379:Mice; D010456:Peptides, Cyclic / Q000494:pharmacology*; D051381:Rats
D005343:Fibrinolytic Agents; D010456:Peptides, Cyclic; C475455:YM-254890; D043802:GTP-Binding Protein alpha Subunits, Gq-G11